NIH-funded research R01 grant

Why muscle cells in the aorta may cause narrowing above the aortic valve

Official title: Investigating altered smooth muscle cell mechanotransduction as a cause of supravalvular aortic stenosis

Funded at Washington University · NIH-11238014 · Data updated 2026-11-12

Researchers are looking at whether changes in how aortic wall muscle cells sense stretch lead to supravalvular aortic stenosis in people with elastin (ELN) gene mutations.

More Aortic Stenosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startDecember 1, 2022
Project endNovember 30, 2026
Funding year2026
Award (this year)$388,750
NIH project number5R01HL166448-04
Project IDNIH-11238014 on NIH RePORTER

Who could benefit from this research

Could help

People with supravalvular aortic stenosis or known ELN (elastin) mutations, including affected children and adults, would be the most directly relevant group.

Less likely to help

Patients with aortic narrowing from other causes (for example age-related calcific aortic valve disease) or without ELN mutations may not see direct benefit from this work.

What this research studies

From a patient's point of view, this work uses a mouse model that mimics elastin loss and lab studies of aortic smooth muscle cells to see how reduced elastin changes artery stiffness and cell stretch. The team measures mechanosensitive Piezo channel activity, calcium signaling, and downstream YAP/TAZ and CTGF pathways that control cell growth and movement. They compare gene and protein changes and cell behaviors to link altered mechanics with the focal narrowing seen in SVAS. The goal is to understand the chain of events that could point to ways to prevent or slow aortic narrowing.

Why it matters

Potential benefit: Could identify molecular pathways or targets that lead to new treatments to prevent or slow aortic narrowing in people with ELN-related SVAS.

How similar studies have gone: Prior studies have linked mechanosensitive channels and YAP/TAZ signaling to vascular cell behavior, but applying Piezo-mediated mechanotransduction specifically to ELN-related SVAS is relatively novel.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Wagenseil, Jessica — Washington University
  • Study coordinator: Wagenseil, Jessica

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.